Current Affairs - Awards and Honours - Discussion

Kirti Ganorkar has been appointed as the Managing Director of Sun Pharmaceutical Industries Ltd, effective from September 1, 2025. This leadership change marks a key phase in Sun Pharma’s succession planning, with founder Dilip Shanghvi transitioning to the role of Executive Chairman to focus on strategic oversight. Ganorkar, a long-standing executive who joined the company in 1996, has held various critical roles in business development, marketing, M&A, and project management. Most recently, he led Sun Pharma’s India Business, driving strong market performance. His appointment reflects the company’s commitment to leadership continuity and a strategic focus on sustained global growth.